Unlock this StockReport nowClick to Unlock

Allergy Therapeutics Share Price

AGY 13.25p 0.0  0.0%
26/06/19 10.00k
StockRank

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 30th Jun 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +1.5%

FINANCIAL BRIEF: For the six months ended 31 December 2018, Allergy Therapeutics plc revenues increased 11% to £46.7M. Net income increased 71% to £10.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Research and development costs decrease of 16% to £5M (expense), Sales, marketing & Distribution Costs decrease of 5% to £13.6M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
D+
D+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
30th Jun 2019
30th Jun 2020

Price Target: 0.39
(+190.61% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
5 brokers Broker Consensus Trend
Broker Recommendations for Allergy Therapeutics
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 1 1 1

Named Brokers and Analysts
Stifel Nicolaus and Company, Incorporated James Mainwaring , Panmure Gordon Mike Mitchell , Hardman & Company Martin Hall , Numis Securities Paul Cuddon , FinnCap Mark Brewer , Zeus Capital ,

Profile Summary

Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.

Directors: Manuel Llobet (CEO) 50, Nicolas Wykeman (FID) 51, Peter Jensen (NEC) 63, Scott Leinenweber (NED) 47, Babatunde Tunde Otulana (NID) 61, Stephen Smith (NID) 61,

No. of Employees: 499 No. of Shareholders: n/a


Last Annual June 30th, 2018
Last Interim December 31st, 2018
Incorporated June 1, 2004
Public Since October 11, 2004
Shares in Issue 636,169,000
Free Float 140.2m (22.0%)
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

AGY Share Price Performance AGY Share Price Quote
13.25p
0.0  0.0%
Traded 12:14pm · Minimum 15 min delayed · NMS: 10.00k

Latest AGY News Announcements (delayed)

Upcoming AGY Events

Recent ↓
Wednesday 6th March, 2019 (estimate)
Half Year 2019 Allergy Therapeutics PLC Earnings Release
Wednesday 6th March, 2019
Half Year 2019 Allergy Therapeutics PLC Earnings Call (German)
Wednesday 14th November, 2018
Allergy Therapeutics PLC at Stifel Healthcare Conference
Wednesday 26th September, 2018 (estimate)
Full Year 2018 Allergy Therapeutics PLC Earnings Release
Wednesday 26th September, 2018
Full Year 2018 Allergy Therapeutics PLC Earnings Call (German)
Wednesday 7th March, 2018 (estimate)
Half Year 2018 Allergy Therapeutics PLC Earnings Release
Thursday 28th September, 2017 (estimate)
Full Year 2017 Allergy Therapeutics PLC Earnings Release
Thursday 28th September, 2017
Full Year 2017 Allergy Therapeutics PLC Earnings Call
Wednesday 29th March, 2017
Half Year 2017 Allergy Therapeutics PLC Earnings Call
Wednesday 29th March, 2017
Half Year 2017 Allergy Therapeutics PLC Earnings Release
Monday 26th September, 2016
Full Year 2016 Allergy Therapeutics PLC Earnings Release
Tuesday 8th March, 2016
Half Year 2016 Allergy Therapeutics PLC Earnings Release
Wednesday 18th November, 2015
Allergy Therapeutics PLC at Jefferies Autumn Global Healthcare Conference
Monday 30th March, 2015
Allergy Therapeutics PLC Ordinary Shareholders Meeting
Monday 2nd March, 2015
Half Year 2015 Allergy Therapeutics PLC Earnings Release
Monday 12th January, 2015
Allergy Therapeutics PLC Trading Statement Release
Wednesday 19th November, 2014
Allergy Therapeutics PLC Annual Shareholders Meeting
Monday 22nd September, 2014
Full Year 2014 Allergy Therapeutics PLC Earnings Release
Thursday 24th July, 2014
Allergy Therapeutics PLC Trading Update for the year to 30 June 2014


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy AGY

Access AGY Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis